HEADER OXIDOREDUCTASE 29-JUN-06 2HI4 TITLE CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 1A2 IN COMPLEX WITH ALPHA- TITLE 2 NAPHTHOFLAVONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYTOCHROME P450 1A2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 26-514; COMPND 5 SYNONYM: CYPIA2, P450-P3, P3, 450, P450 4; COMPND 6 EC: 1.14.14.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CYP1A2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: DH5ALPHA; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PCWORI KEYWDS CYP1A2, P450 1A2, P450, MONOOXYGENASE, DRUG METABOLIZING ENZYME, KEYWDS 2 ALPHA-NAPHTHOFLAVONE, BENZO(H)FLAVONE, 7, 8-BENZOFLAVONE, KEYWDS 3 OXIDOREDUCTASE, HEME EXPDTA X-RAY DIFFRACTION AUTHOR S.SANSEN,J.K.YANO,R.L.REYNALD,G.S.SCHOCH,C.D.STOUT,E.F.JOHNSON REVDAT 4 18-OCT-17 2HI4 1 REMARK REVDAT 3 24-FEB-09 2HI4 1 VERSN REVDAT 2 31-JUL-07 2HI4 1 JRNL REVDAT 1 20-FEB-07 2HI4 0 JRNL AUTH S.SANSEN,J.K.YANO,R.L.REYNALD,G.A.SCHOCH,K.J.GRIFFIN, JRNL AUTH 2 C.D.STOUT,E.F.JOHNSON JRNL TITL ADAPTATIONS FOR THE OXIDATION OF POLYCYCLIC AROMATIC JRNL TITL 2 HYDROCARBONS EXHIBITED BY THE STRUCTURE OF HUMAN P450 1A2. JRNL REF J.BIOL.CHEM. V. 282 14348 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17311915 JRNL DOI 10.1074/JBC.M611692200 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.51 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2726889.250 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.1 REMARK 3 NUMBER OF REFLECTIONS : 38022 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.267 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1871 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.07 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6145 REMARK 3 BIN R VALUE (WORKING SET) : 0.3710 REMARK 3 BIN FREE R VALUE : 0.3830 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 325 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.021 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3845 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 160 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.73 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 24.99000 REMARK 3 B22 (A**2) : -12.86000 REMARK 3 B33 (A**2) : -12.13000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM SIGMAA (A) : 0.37 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.41 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.019 REMARK 3 BOND ANGLES (DEGREES) : 2.000 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.260 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.42 REMARK 3 BSOL : 68.45 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : XDICT_HEME_RELAX.PAR REMARK 3 PARAMETER FILE 4 : BHF.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : XDICT_HEME.TOP REMARK 3 TOPOLOGY FILE 4 : BHF.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2HI4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JUN-06. REMARK 100 THE DEPOSITION ID IS D_1000038372. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-APR-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97945 REMARK 200 MONOCHROMATOR : SIDE SCATTERING BENT CUBE-ROOT I REMARK 200 -BEAM SINGLE CRYSTAL; ASYMMETRIC REMARK 200 CUT 4.965 DEGS REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING); REMARK 200 SINGLE CRYSTAL SI(111) BENT REMARK 200 MONOCHROMATOR (HO RIZONTAL REMARK 200 FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41139 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 88.045 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.2 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.09200 REMARK 200 R SYM (I) : 0.09200 REMARK 200 FOR THE DATA SET : 4.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : 0.39400 REMARK 200 R SYM FOR SHELL (I) : 0.39400 REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: CYP2A6, PDB ENTRY 1Z10 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.02 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG3350, TRIS, AMMONIUM NITRATE, CYMAL REMARK 280 -6 (CYCLOHEXYL-HEXYL-BETA-D-MALTOSIDE), C12E8 REMARK 280 (OCTAETHYLENEGLYCOL MONO-N-DODECYL ETHER) , PH 8.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 39.81500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 40.41000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 87.91000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 39.81500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 40.41000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 87.91000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 39.81500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 40.41000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 87.91000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 39.81500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 40.41000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 87.91000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY HAS NOT BEEN DETERMINED BUT THOUGHT REMARK 300 TO BE A MONOMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 25 REMARK 465 ALA A 26 REMARK 465 VAL A 27 REMARK 465 LEU A 28 REMARK 465 LYS A 29 REMARK 465 GLY A 30 REMARK 465 LEU A 31 REMARK 465 ARG A 32 REMARK 465 PRO A 33 REMARK 465 ILE A 514 REMARK 465 ASN A 515 REMARK 465 HIS A 516 REMARK 465 HIS A 517 REMARK 465 HIS A 518 REMARK 465 HIS A 519 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 243 NE - CZ - NH1 ANGL. DEV. = 4.0 DEGREES REMARK 500 ARG A 243 NE - CZ - NH2 ANGL. DEV. = -3.8 DEGREES REMARK 500 LEU A 382 CA - CB - CG ANGL. DEV. = -18.1 DEGREES REMARK 500 ARG A 392 NE - CZ - NH2 ANGL. DEV. = -3.9 DEGREES REMARK 500 ARG A 456 NE - CZ - NH2 ANGL. DEV. = -5.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 50 -48.38 71.10 REMARK 500 VAL A 99 -66.61 -107.33 REMARK 500 THR A 118 -114.17 41.20 REMARK 500 SER A 129 24.28 -145.05 REMARK 500 SER A 148 -78.66 -138.94 REMARK 500 SER A 157 -14.89 -151.68 REMARK 500 ALA A 230 58.29 -91.78 REMARK 500 ASP A 274 64.31 -101.92 REMARK 500 SER A 279 74.96 -151.69 REMARK 500 LEU A 365 58.51 -112.69 REMARK 500 GLU A 422 -85.70 -53.49 REMARK 500 CYS A 458 125.60 -38.06 REMARK 500 ARG A 511 -176.26 -69.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 900 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 458 SG REMARK 620 2 HEM A 900 NA 105.2 REMARK 620 3 HEM A 900 NB 93.6 91.6 REMARK 620 4 HEM A 900 NC 88.7 165.7 84.2 REMARK 620 5 HEM A 900 ND 106.1 85.3 160.2 93.9 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 900 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BHF A 800 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1Z10 RELATED DB: PDB REMARK 900 HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND, USED AS MR SEARCH REMARK 900 PROBE REMARK 900 RELATED ID: 1PQ2 RELATED DB: PDB REMARK 900 HUMAN DRUG METABOLIZING FAMILY 2 P450 2C8 REMARK 900 RELATED ID: 1R90 RELATED DB: PDB REMARK 900 HUMAN DRUG METABOLIZING FAMILY 2 P450 2C9 REMARK 900 RELATED ID: 1TQN RELATED DB: PDB REMARK 900 HUMAN DRUG METABOLIZING FAMILY 3 P450 3A4 DBREF 2HI4 A 27 515 UNP P05177 CP1A2_HUMAN 26 514 SEQADV 2HI4 MET A 25 UNP P05177 CLONING ARTIFACT SEQADV 2HI4 ALA A 26 UNP P05177 CLONING ARTIFACT SEQADV 2HI4 HIS A 516 UNP P05177 EXPRESSION TAG SEQADV 2HI4 HIS A 517 UNP P05177 EXPRESSION TAG SEQADV 2HI4 HIS A 518 UNP P05177 EXPRESSION TAG SEQADV 2HI4 HIS A 519 UNP P05177 EXPRESSION TAG SEQRES 1 A 495 MET ALA VAL LEU LYS GLY LEU ARG PRO ARG VAL PRO LYS SEQRES 2 A 495 GLY LEU LYS SER PRO PRO GLU PRO TRP GLY TRP PRO LEU SEQRES 3 A 495 LEU GLY HIS VAL LEU THR LEU GLY LYS ASN PRO HIS LEU SEQRES 4 A 495 ALA LEU SER ARG MET SER GLN ARG TYR GLY ASP VAL LEU SEQRES 5 A 495 GLN ILE ARG ILE GLY SER THR PRO VAL LEU VAL LEU SER SEQRES 6 A 495 ARG LEU ASP THR ILE ARG GLN ALA LEU VAL ARG GLN GLY SEQRES 7 A 495 ASP ASP PHE LYS GLY ARG PRO ASP LEU TYR THR SER THR SEQRES 8 A 495 LEU ILE THR ASP GLY GLN SER LEU THR PHE SER THR ASP SEQRES 9 A 495 SER GLY PRO VAL TRP ALA ALA ARG ARG ARG LEU ALA GLN SEQRES 10 A 495 ASN ALA LEU ASN THR PHE SER ILE ALA SER ASP PRO ALA SEQRES 11 A 495 SER SER SER SER CYS TYR LEU GLU GLU HIS VAL SER LYS SEQRES 12 A 495 GLU ALA LYS ALA LEU ILE SER ARG LEU GLN GLU LEU MET SEQRES 13 A 495 ALA GLY PRO GLY HIS PHE ASP PRO TYR ASN GLN VAL VAL SEQRES 14 A 495 VAL SER VAL ALA ASN VAL ILE GLY ALA MET CYS PHE GLY SEQRES 15 A 495 GLN HIS PHE PRO GLU SER SER ASP GLU MET LEU SER LEU SEQRES 16 A 495 VAL LYS ASN THR HIS GLU PHE VAL GLU THR ALA SER SER SEQRES 17 A 495 GLY ASN PRO LEU ASP PHE PHE PRO ILE LEU ARG TYR LEU SEQRES 18 A 495 PRO ASN PRO ALA LEU GLN ARG PHE LYS ALA PHE ASN GLN SEQRES 19 A 495 ARG PHE LEU TRP PHE LEU GLN LYS THR VAL GLN GLU HIS SEQRES 20 A 495 TYR GLN ASP PHE ASP LYS ASN SER VAL ARG ASP ILE THR SEQRES 21 A 495 GLY ALA LEU PHE LYS HIS SER LYS LYS GLY PRO ARG ALA SEQRES 22 A 495 SER GLY ASN LEU ILE PRO GLN GLU LYS ILE VAL ASN LEU SEQRES 23 A 495 VAL ASN ASP ILE PHE GLY ALA GLY PHE ASP THR VAL THR SEQRES 24 A 495 THR ALA ILE SER TRP SER LEU MET TYR LEU VAL THR LYS SEQRES 25 A 495 PRO GLU ILE GLN ARG LYS ILE GLN LYS GLU LEU ASP THR SEQRES 26 A 495 VAL ILE GLY ARG GLU ARG ARG PRO ARG LEU SER ASP ARG SEQRES 27 A 495 PRO GLN LEU PRO TYR LEU GLU ALA PHE ILE LEU GLU THR SEQRES 28 A 495 PHE ARG HIS SER SER PHE LEU PRO PHE THR ILE PRO HIS SEQRES 29 A 495 SER THR THR ARG ASP THR THR LEU ASN GLY PHE TYR ILE SEQRES 30 A 495 PRO LYS LYS CYS CYS VAL PHE VAL ASN GLN TRP GLN VAL SEQRES 31 A 495 ASN HIS ASP PRO GLU LEU TRP GLU ASP PRO SER GLU PHE SEQRES 32 A 495 ARG PRO GLU ARG PHE LEU THR ALA ASP GLY THR ALA ILE SEQRES 33 A 495 ASN LYS PRO LEU SER GLU LYS MET MET LEU PHE GLY MET SEQRES 34 A 495 GLY LYS ARG ARG CYS ILE GLY GLU VAL LEU ALA LYS TRP SEQRES 35 A 495 GLU ILE PHE LEU PHE LEU ALA ILE LEU LEU GLN GLN LEU SEQRES 36 A 495 GLU PHE SER VAL PRO PRO GLY VAL LYS VAL ASP LEU THR SEQRES 37 A 495 PRO ILE TYR GLY LEU THR MET LYS HIS ALA ARG CYS GLU SEQRES 38 A 495 HIS VAL GLN ALA ARG ARG PHE SER ILE ASN HIS HIS HIS SEQRES 39 A 495 HIS HET HEM A 900 43 HET BHF A 800 21 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM BHF 2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE HETSYN HEM HEME HETSYN BHF 7,8-BENZOFLAVONE; ALPHA-NAPHTHOFLAVONE FORMUL 2 HEM C34 H32 FE N4 O4 FORMUL 3 BHF C19 H12 O2 FORMUL 4 HOH *160(H2 O) HELIX 1 1 HIS A 53 GLY A 58 1 6 HELIX 2 2 ASN A 60 GLY A 73 1 14 HELIX 3 3 ARG A 90 VAL A 99 1 10 HELIX 4 4 GLN A 101 PHE A 105 5 5 HELIX 5 5 LEU A 111 LEU A 116 1 6 HELIX 6 6 GLY A 130 PHE A 147 1 18 HELIX 7 7 CYS A 159 GLY A 182 1 24 HELIX 8 8 ASP A 187 GLY A 206 1 20 HELIX 9 9 GLN A 207 PHE A 209 5 3 HELIX 10 10 SER A 213 LYS A 221 1 9 HELIX 11 11 THR A 223 GLU A 228 1 6 HELIX 12 12 ASN A 234 PHE A 238 5 5 HELIX 13 13 PHE A 239 LEU A 245 5 7 HELIX 14 14 ASN A 247 ASP A 274 1 28 HELIX 15 15 ASP A 282 GLY A 294 1 13 HELIX 16 16 GLN A 304 ASN A 309 1 6 HELIX 17 17 ASN A 309 LYS A 336 1 28 HELIX 18 18 LYS A 336 ILE A 351 1 16 HELIX 19 19 ARG A 358 ARG A 362 5 5 HELIX 20 20 LEU A 365 SER A 380 1 16 HELIX 21 21 ASN A 410 ASP A 417 1 8 HELIX 22 22 ARG A 428 LEU A 433 5 6 HELIX 23 23 ASN A 441 GLU A 446 1 6 HELIX 24 24 MET A 453 ARG A 457 5 5 HELIX 25 25 GLY A 460 LEU A 479 1 20 SHEET 1 A 4 VAL A 75 ILE A 80 0 SHEET 2 A 4 THR A 83 LEU A 88 -1 O VAL A 87 N LEU A 76 SHEET 3 A 4 CYS A 406 VAL A 409 1 O CYS A 406 N LEU A 86 SHEET 4 A 4 HIS A 388 SER A 389 -1 N HIS A 388 O VAL A 407 SHEET 1 B 2 ARG A 296 ALA A 297 0 SHEET 2 B 2 ASN A 300 LEU A 301 -1 O ASN A 300 N ALA A 297 SHEET 1 C 2 THR A 394 LEU A 396 0 SHEET 2 C 2 PHE A 399 ILE A 401 -1 O ILE A 401 N THR A 394 SHEET 1 D 2 GLU A 480 SER A 482 0 SHEET 2 D 2 GLN A 508 ARG A 510 -1 O GLN A 508 N SER A 482 LINK FE HEM A 900 SG CYS A 458 1555 1555 2.35 SITE 1 AC1 23 ARG A 108 THR A 124 TRP A 133 ARG A 137 SITE 2 AC1 23 LEU A 144 ILE A 314 ALA A 317 GLY A 318 SITE 3 AC1 23 THR A 321 PHE A 376 PHE A 381 LEU A 382 SITE 4 AC1 23 THR A 385 ILE A 386 HIS A 388 GLN A 411 SITE 5 AC1 23 LEU A 450 PHE A 451 ARG A 456 CYS A 458 SITE 6 AC1 23 ILE A 459 ALA A 464 HOH A 694 SITE 1 AC2 10 THR A 118 PHE A 226 PHE A 260 ASP A 313 SITE 2 AC2 10 GLY A 316 ALA A 317 ASP A 320 THR A 321 SITE 3 AC2 10 LEU A 497 HOH A 733 CRYST1 79.630 80.820 175.820 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012558 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012373 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005688 0.00000 MASTER 350 0 2 25 10 0 9 6 0 0 0 39 END